Print ISSN:-2581-5555

Online ISSN:-2456-9542

CODEN : IIJCDU


Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 1060

PDF Downloaded: 516


Evaluation of CD4 count in patients receiving ART treatment in a tertiary rural hospital of India


Full Text PDF Share on Facebook Share on Twitter


Original Article

Author Details : Renge PS, Narwane Sandeep Prakash*

Volume : 5, Issue : 1, Year : 2020

Article Page : 22-24

https://doi.org/10.18231/j.ijcaap.2020.006



Suggest article by email

Get Permission

Abstract

Introduction: The present study was aimed to evaluate the efficacy of new ART treatment as per the recent guidelines in treatment of AIDS patients by NACO on patients’ CD4 count after 6 months of treatment.
Materials and Methods: The present study was Descriptive longitudinal type conducted in ART centre of Pravara Rural Hospital, Loni. The demography, Co-morbidities, ART treatment and CD4 count before and after first 6 months of therapy were recorded.
Results: In the present study, records of 100 patients were collected. Out of the 100 patients 38 were males, females were 62 and 1 transgender patient. Ninety one out of 100 patients were prescribed Tenofovir + Lamivudine + Efavirenz (TLE). There was a statistically significant increase in the CD4 count before (416.7 ± 322) and after ART treatment at an interval of 6 months (520.89 ± 317).
Conclusion: The initiation of ART in patients irrespective of CD4 count has been an improvement in the treatment therapy of HIV infected patients.

Keywords: ART, AIDS, HIV infection, CD4 count.



How to cite : Renge Ps, Prakash N S, Evaluation of CD4 count in patients receiving ART treatment in a tertiary rural hospital of India. IP Int J Compr Adv Pharmacol 2020;5(1):22-24


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.